Drug Shortage Report for MS.IR
| Report ID | 101855 |
| Drug Identification Number | 02014254 |
| Brand name | MS.IR |
| Common or Proper name | Morphine Sulfate |
| Company Name | PURDUE PHARMA |
| Market Status | MARKETED |
| Active Ingredient(s) | MORPHINE SULFATE |
| Strength(s) | 30MG |
| Dosage form(s) | TABLET (IMMEDIATE RELEASE) |
| Route of administration | ORAL |
| Packaging size | 60 |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2019-12-20 |
| Actual start date | 2019-12-20 |
| Estimated end date | 2020-03-20 |
| Actual end date | 2020-03-17 |
| Shortage status | Resolved |
| Updated date | 2020-03-23 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2020-03-23 | French | Compare |
| v7 | 2020-03-23 | English | Compare |
| v6 | 2020-01-24 | French | Compare |
| v5 | 2020-01-24 | English | Compare |
| v4 | 2019-12-21 | English | Compare |
| v3 | 2019-12-20 | French | Compare |
| v2 | 2019-12-20 | English | Compare |
| v1 | 2019-12-20 | English | Compare |
Showing 1 to 8 of 8